↓ Skip to main content

Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD

Overview of attention for article published in New England Journal of Medicine, May 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Citations

dimensions_citation
284 Dimensions

Readers on

mendeley
304 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
Published in
New England Journal of Medicine, May 2014
DOI 10.1056/nejmoa1403086
Pubmed ID
Authors

Gerard J Criner, John E Connett, Shawn D Aaron, Richard K Albert, William C Bailey, Richard Casaburi, J Allen D Cooper, Jeffrey L Curtis, Mark T Dransfield, MeiLan K Han, Barry Make, Nathaniel Marchetti, Fernando J Martinez, Dennis E Niewoehner, Paul D Scanlon, Frank C Sciurba, Steven M Scharf, Don D Sin, Helen Voelker, George R Washko, Prescott G Woodruff, Stephen C Lazarus

Abstract

Retrospective studies have shown that statins decrease the rate and severity of exacerbations, the rate of hospitalization, and mortality in chronic obstructive pulmonary disease (COPD). We prospectively studied the efficacy of simvastatin in preventing exacerbations in a large, multicenter, randomized trial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 77 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 304 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 3 <1%
Brazil 2 <1%
Netherlands 2 <1%
United States 2 <1%
United Kingdom 1 <1%
Denmark 1 <1%
Canada 1 <1%
Japan 1 <1%
Mexico 1 <1%
Other 0 0%
Unknown 290 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 51 17%
Student > Ph. D. Student 31 10%
Other 29 10%
Student > Master 29 10%
Student > Postgraduate 24 8%
Other 91 30%
Unknown 49 16%
Readers by discipline Count As %
Medicine and Dentistry 164 54%
Pharmacology, Toxicology and Pharmaceutical Science 16 5%
Nursing and Health Professions 15 5%
Agricultural and Biological Sciences 15 5%
Immunology and Microbiology 6 2%
Other 23 8%
Unknown 65 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 177. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#228,117
of 25,387,668 outputs
Outputs from New England Journal of Medicine
#4,187
of 32,476 outputs
Outputs of similar age
#1,783
of 241,408 outputs
Outputs of similar age from New England Journal of Medicine
#33
of 255 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,476 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.0. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 255 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.